BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oliveira-sena IV, Werneck GL. Risk factors for in-hospital mortality from visceral leishmaniasis: A case-control study. Journal of Infection and Public Health 2020;13:538-43. [DOI: 10.1016/j.jiph.2019.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Abdullahi B, Mutiso J, Maloba F, Macharia J, Riongoita M, Gicheru M, Chowdhury R. Climate Change and Environmental Influence on Prevalence of Visceral Leishmaniasis in West Pokot County, Kenya. Journal of Tropical Medicine 2022;2022:1-6. [DOI: 10.1155/2022/1441576] [Reference Citation Analysis]
2 Abdullahi B, Mutiso J, Maloba F, Macharia J, Riongoita M, Gicheru M. Climate change and environmental influence on visceral leishmaniasis in West Pokot county, Kenya.. [DOI: 10.1101/2022.05.08.22274805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Castillo-Castañeda A, Herrera G, Ayala MS, Fuya P, Ramírez JD. Spatial and Temporal Variability of Visceral Leishmaniasis in Colombia, 2007 to 2018. Am J Trop Med Hyg 2021;105:144-55. [PMID: 34232908 DOI: 10.4269/ajtmh.21-0103] [Reference Citation Analysis]
4 Tabrez S, Rahman F, Ali R, Muhammad F, Alshehri BM, Alaidarous MA, Banawas S, Dukhyil AAB, Rub A. Repurposing of FDA-approved drugs as inhibitors of sterol C-24 methyltransferase of Leishmania donovani to fight against leishmaniasis. Drug Dev Res 2021. [PMID: 33929761 DOI: 10.1002/ddr.21820] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]